How the Treatment of Lung Cancer Has Been Transformed in the Era of Molecular Biomarker Testing

David L. Rimm, MD, PhD; Roy Herbst, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs Roy Herbst and David Rimm review how biomarker testing has transformed the way patients with lung cancer are treated, and how both medical oncologists and pathologists contribute to these changes.

September 20, 2013

Justifying the Value of Personalized Medicine

Matthew Palmgren presents the key issues that help justify the value and cost of personalized medicines

September 2, 2015

Challenges with Oral Oncolytics for Healthcare Practitioners

As more oral oncolytics are developed, choosing the right regimen for prolonged disease-free survival presents a major patient management challenge. Dixie-Lee Esseltine, MD and George Mulligan, PhD explain that healthcare practitioners will have to make informed choices by balancing information emerging across similar trials.